http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009514970-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168
filingDate 2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009514970-A
titleOfInvention Treatment of length-dependent neuropathy
abstract Painful by locally or locally delivering compounds that interact with α2 adrenergic receptors, particularly α2 adrenergic agonists such as clonidine, to the entire painful area so that the need for systemic administration is minimized Compositions for the treatment of sexual neuropathy and methods of use thereof are provided. The compounds are delivered to or adjacent to the painful area of patients with painful length-dependent neuropathy and other neuropathies that affect cutaneous pain signaling fibers. Preferred compounds for the treatment of patients with length-dependent neuropathy are clonidine administered in transdermal patches, gels, ointments, lotions, liposomal formulations, creams or emulsions, in which case the concentration is painful It is sufficient to provide an effective dose to a region or a region immediately adjacent thereto.
priorityDate 2005-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003512427-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6054461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007025613-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54688690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457798390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415740959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394869
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457501988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407698407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457629203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409240959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425035971

Total number of triples: 84.